5 Star Review

"Most helpful, steered us in the right direction for treatmen...." see more

Elaine C. - Mesothelioma Patient

5 Star Review

"Because of their guidance, I was able to navigate getting my...." see more

Deanna B. - Daughter of a Mesothelioma Patient

5 Star Review

"Hearing the news about my mother's diagnosis was heartbreaki...." see more

Danielle W. - Daughter of a Mesothelioma Patient

5 Star Review

"My son Carlos was diagnosed with this terrible and unknown d...." see more

Martha M. - Mother of a Mesothelioma Patient

5 Star Review

"Extremely communicative and helped my dad get an appointment...." see more

Sunni H. - Loved One of a Mesothelioma Patient

5 Star Review

"Danielle DiPietro was an invaluable resource for me. Her sug...." see more

Deborah C. - Spouse of a Mesothelioma Patient

5 Star Review

"I was very grateful and appreciative of Dr. Smart from The M...." see more

Kimberlin C. - Spouse of a Mesothelioma Patient

5 Star Review

"In January of 2016, my husband was diagnosed with peritoneal...." see more

Gloria R. - Spouse of a Mesothelioma Patient

Expertise:
Cytoreductive Surgery
HIPEC
Speciality:
Surgical Oncology
Gender:
Female
Language:
English, Bengali, Hindi, Tamil

Get to Know Dr. Sharmila Roy Chowdhury

Surgical oncologist Dr. Sharmila Roy Chowdhury specializes in the use of novel hyperthermic intraperitoneal chemotherapy, known as HIPEC, which has dramatically improved treatment for peritoneal mesothelioma cancer.

Chowdhury uses HIPEC in combination with cytoreductive surgery in treating several different abdominal malignancies.

Her practice at Goshen Center for Cancer Care in Goshen, Indiana, focuses on gastrointestinal oncology and rare cancers such as pseudomyxoma peritonei, appendix cancer and mesothelioma. She also treats peritoneal carcinomatosis, stomach cancer and liver cancer.

While many doctors, and even oncologists, struggle with properly identifying peritoneal mesothelioma, Chowdhury has extensive experience with mesothelioma treatment.

Chowdhury is the former director of the Peritoneal Surface Malignancy and HIPEC Program at Medical City Plano, and started similar programs at Indiana University Hospital and Loma Linda University Medical Center in California.

Specialties of Dr. Sharmila Roy Chowdhury

  • Peritoneal mesothelioma
  • Gastrointestinal oncology
  • Peritoneal carcinomatosis
  • Cytoreductive surgery
  • HIPEC

Dr. Sharmila Roy Chowdhury’s Experience and Education

  • Goshen Center for Cancer Care
  • Southwest Cancer Surgery
  • Medical City Plano
  • Indiana University Hospital
  • Loma Linda University Medical Center
  • University of Pittsburgh Medical Center (Fellowship)
  • Seth G.S. Medical College and K.E.M. Hospitals (Residency)
  • Providence Hospital and Medical Centers (Residency)
  • Staten Island University Hospital (Residency)
  • Rutgers New Jersey Medical School (Residency)
  • Jawaharlal Institute of Postgraduate Medical Education and Research (M.D.)

Awards and Certifications

  • Society of Surgical Oncology Accredited Fellowship
  • Trustees’ Teaching Award, Indiana University School of Medicine (2015)
  • ASCO Merit Award (2005)
  • Board certified in surgery

Publications of Dr. Sharmila Roy Chowdhury

  • Roos, M. et al. (2010, October). The impact of multidisciplinary therapy in node-positive rectal cancer. American Journal of Surgery.
  • Kuo, J. et al. (2010, October). The use of pelvic radiation in stage II rectal cancer: a population based analysis. American Journal of Surgery.
  • Olaya, W. et al. (2009, October). Disparities in the surgical management of women with stage I breast cancer. American Journal of Surgery.